Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

VKTX

Viking Therapeutics Inc

Dec 11 • 04:00PM ET

49.21

Dollar change +1.36
Percentage change 2.84	%

Healthcare • Biotechnology • USA • NASD

Peers: MDGL AKRO GLMD AKBA PRTG ARDX BOLD CARA EYPT FGEN

| Held by: VTI VB XBI VXF VBK IWP SCHA VHT IWF IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.94	Insider Own	3.04%	Shs Outstand	111.43M	Perf Week	-3.96%
Market Cap	5.48B	Forward P/E	-	EPS next Y	-1.48	Insider Trans	-16.99%	Shs Float	108.05M	Perf Month	-21.85%
Income	-99.15M	PEG	-	EPS next Q	-0.28	Inst Own	73.78%	Short Float	16.73%	Perf Quarter	-21.65%
Sales	0.00M	P/S	-	EPS this Y	-5.80%	Inst Trans	1.74%	Short Ratio	4.31	Perf Half Y	-6.20%
Book/sh	8.18	P/B	6.02	EPS next Y	-53.29%	ROA	-15.02%	Short Interest	18.07M	Perf Year	182.01%
Cash/sh	8.35	P/C	5.89	EPS next 5Y	40.00%	ROE	-15.50%	52W Range	16.70 - 99.41	Perf YTD	164.43%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-18.89%	ROI	-10.87%	52W High	-50.50%	Beta	0.89
Dividend TTM	-	Quick Ratio	36.47	Sales past 5Y	0.00%	Gross Margin	-	52W Low	194.67%	ATR (14)	3.20
Dividend Ex-Date	-	Current Ratio	36.47	EPS Y/Y TTM	-1.31%	Oper. Margin	-	RSI (14)	37.72	Volatility	4.78% 5.80%
Employees	27	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	110.00
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	0.35%	Payout	-	Rel Volume	0.50	Prev Close	47.85
Sales Surprise	-	EPS Surprise	9.43%	Sales Q/Q	-	Earnings	Oct 23 AMC	Avg Volume	4.20M	Price	49.21
SMA20	-4.31%	SMA50	-18.74%	SMA200	-22.09%	Trades		Volume	2,112,210	Change	2.84%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-24	Initiated	Piper Sandler	Overweight
Nov-22-24	Initiated	B. Riley Securities	Buy	$109
Nov-04-24	Reiterated	H.C. Wainwright	Buy	$90 → $102
Sep-11-24	Initiated	JP Morgan	Overweight	$80
Jun-27-24	Initiated	Morgan Stanley	Overweight	$105
May-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$115 → $116
Mar-26-24	Reiterated	Oppenheimer	Outperform	$116 → $138
Mar-07-24	Initiated	Jefferies	Buy	$110
Feb-28-24	Reiterated	Oppenheimer	Outperform	$46 → $116
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22
Jul-29-21	Resumed	BTIG Research	Buy	$20
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform	$27 → $12
Jun-05-20	Initiated	BMO Capital Markets	Outperform	$14
May-05-20	Initiated	Chardan Capital Markets	Buy	$15
May-01-20	Initiated	BTIG Research	Buy	$9
Jul-16-19	Initiated	Oppenheimer	Outperform	$12
Jun-25-19	Initiated	Stifel	Buy
Mar-29-19	Upgrade	SVB Leerink	Mkt Perform → Outperform	$10 → $21

Show Previous Ratings

Dec-10-24 04:10AM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
Dec-05-24 07:15AM	Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? (Motley Fool)
Dec-03-24 08:27AM	After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now? (Motley Fool)
07:00AM	2 Disruptive Growth Stocks With Room to Run (Motley Fool)
Nov-28-24 01:17PM	Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow (Motley Fool)
05:16PM	Loading…
Nov-26-24 05:16PM	Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment (Investor's Business Daily)
01:04PM	Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment (Investor's Business Daily)
Nov-25-24 04:21AM	Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst (Motley Fool)
Nov-23-24 06:30AM	3 Monster Stocks in the Making (Motley Fool)
Nov-22-24 04:17PM	RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried? (Investor's Business Daily)
11:31AM	Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report? (Zacks)
08:00AM	Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry? (Investor's Business Daily)
Nov-21-24 04:46PM	Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential? (Insider Monkey)
Nov-20-24 01:26PM	Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs (Benzinga)
Nov-19-24 04:03PM	Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024 (PR Newswire)
04:45AM	Loading…
Nov-18-24 04:45AM	3 Things You Need to Know if You Buy Viking Therapeutics Today (Motley Fool)
Nov-17-24 07:05AM	Is It Too Late to Buy Viking Therapeutics Stock? (Motley Fool)
Nov-16-24 05:30AM	Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On. (Motley Fool)
Nov-15-24 04:05AM	Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead? (Motley Fool) -7.45%
Nov-13-24 04:06PM	Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? (Investor's Business Daily) -9.14%
09:45AM	Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly? (Motley Fool)
Nov-12-24 04:05PM	Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024 (PR Newswire)
Nov-10-24 05:15AM	Is Viking Therapeutics a Buy on the Dip? (Motley Fool)
Nov-08-24 07:10AM	4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move (Motley Fool)
Nov-07-24 10:15AM	Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag (Motley Fool)
07:00AM	Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance (Business Wire)
Nov-05-24 01:02PM	Viking Therapeutics Offers An Obesity Drug for Healthy Adults (GuruFocus.com)
10:03AM	Viking stock fluctuates amid manufacturing concerns with obesity pill (Clinical Trials Arena)
04:23AM	Is Viking Therepautics a Buy Now? (Motley Fool)
Nov-04-24 06:48PM	Viking Therapeutics soars then drops on obesity data (CNBC TV) -13.36%
06:33PM	Loading…
06:33PM	Why Viking Therapeutics Stock Plummeted After Soaring Today (Motley Fool)
04:16PM	What Wall Street Analysts Think of Novo Nordisk's Stock Ahead of Earnings (Investopedia)
04:10PM	Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat (Investor's Business Daily)
04:00PM	Viking Therapeutics stock falling amid results for new GLP-1 pill (Yahoo Finance Video)
02:59PM	These Stocks Are Moving the Most Today: Nvidia, Intel, Apple, Sherwin-Williams, Talen, Constellation Energy, DJT, Peloton, and More (Barrons.com)
01:38PM	Stocks to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel (The Wall Street Journal)
12:31PM	Viking Tops Novo As Obesity Pill Brawl Continues, But Shares Dive (Investor's Business Daily)
12:08PM	Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results (Investopedia)
10:39AM	A new weight loss pill outperformed Novo Nordisk's version (Quartz)
10:27AM	Viking Therapeutics, Roblox, Trump Media: 3 Stocks In Focus (Yahoo Finance Video)
09:59AM	This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo. (Barrons.com)
09:53AM	Viking Therapeutics Tops Novo Nordisk As Obesity Pill Brawl Continues (Investor's Business Daily)
09:43AM	Stock to Watch Monday: Trump Media, Viking Therapeutics, Nvidia, Intel (The Wall Street Journal)
09:36AM	Viking Therapeutics Slashes Huge Gains On Latest Obesity Drug Data (Investor's Business Daily)
08:22AM	Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety (Benzinga)
07:22AM	Viking Therapeutics Jumps On Latest Obesity Drug Data (Investor's Business Daily)
07:14AM	Nvidia to join Dow, election looms for Wall Street: Yahoo Finance (Yahoo Finance Video)
07:06AM	Viking Therapeutics Set To Break Out On Latest Obesity Drug Data (Investor's Business Daily)
07:00AM	Big Pharmas Obesity Bonanza Faces New Tests (The Wall Street Journal)
06:30AM	Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek 2024 (PR Newswire)
06:27AM	This Pharma Stock Is Soaring 21%. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo. (Barrons.com)
04:48AM	Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data (Investor's Business Daily)
Nov-01-24 04:08PM	Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH (Investor's Business Daily)
Oct-31-24 04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
05:45AM	This High-Flying Stock Just Became a Better Buy (Motley Fool)
Oct-30-24 11:23AM	Viking Therapeutics CFO Cashes Out: $10M in Shares Sold Amidst Stock Surge (GuruFocus.com)
Oct-29-24 04:11PM	Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen. (Investor's Business Daily)
Oct-28-24 04:05PM	Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek 2024 (PR Newswire)
Oct-27-24 10:45AM	Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution? (Motley Fool)
Oct-24-24 06:28PM	Viking Therapeutics' shares soar on fresh weight-loss medication hopes (CNBC TV) +21.25% +6.57%
04:55PM	Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday (Motley Fool)
04:54PM	Viking Therapeutics stock soars on heels of Q3 beat (Yahoo Finance Video)
04:04PM	Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet (Investor's Business Daily)
03:06PM	Viking Therapeutics Soars 21%: Is This Obesity Drug the Next Blockbuster Weight Loss Treatment? (GuruFocus.com)
12:21PM	Q3 2024 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
09:48AM	How Viking Therapeutics Just Dealt A Blow To Eli Lilly's Obesity Triplet (Investor's Business Daily)
09:17AM	Health and Wellness Industry Embraces Surge in Demand for Weight Loss Drugs (PR Newswire)
08:20AM	3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia) (Motley Fool)
03:10AM	Viking Therapeutics Inc (VKTX) Q3 2024 Earnings Call Highlights: Strong Financial Position Amid ... (GuruFocus.com)
Oct-23-24 04:05PM	Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update (PR Newswire)
Oct-18-24 05:45PM	Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider (Zacks)
03:04PM	State Street Corp's Strategic Reduction in Viking Therapeutics Holdings (GuruFocus.com)
Oct-17-24 08:30AM	Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future (Motley Fool)
Oct-16-24 05:50PM	Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know (Zacks)
04:05PM	Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024 (PR Newswire)
Oct-14-24 04:05PM	Why Amgen's Obesity Drug And $5 Billion Opportunity Led To A Downgrade (Investor's Business Daily)
09:30AM	Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? (Zacks)
05:32AM	Where Will Viking Therapeutics Be in 5 Years? (Motley Fool)
Oct-13-24 12:11PM	Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics (Motley Fool)
Oct-12-24 03:15AM	The Ultimate Biotech Stock to Buy With $100 Right Now (Motley Fool)
Oct-10-24 05:50PM	Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market (Zacks) +5.43%
10:32AM	Viking reports data from X-linked adrenoleukodystrophy trial (Clinical Trials Arena)
Oct-09-24 10:11AM	Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams (Benzinga) -6.06%
07:00AM	Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD (PR Newswire)
Oct-07-24 05:49PM	Viking Therapeutics, Inc. (VKTX): A Hot Stock to Buy Now (Insider Monkey) +5.82%
05:29AM	2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts (Motley Fool)
Oct-04-24 05:45PM	Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts (Zacks)
08:00AM	As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer (Investor's Business Daily)
Oct-03-24 05:50PM	Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today (Zacks)
Oct-02-24 05:00AM	Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now (Quartz)
Sep-30-24 06:34PM	Why Viking Therapeutics Stock Topped the Market Today (Motley Fool)
Sep-29-24 08:30AM	Is Viking Therapeutics Stock a Buy? (Motley Fool)
06:17AM	Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024? (Insider Monkey)
Sep-28-24 07:03AM	Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics (Motley Fool)
Sep-27-24 05:45PM	Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Sep-26-24 08:22PM	Is Viking Therapeutics Inc. (VKTX) the Best Performing Small-Cap Stock in 2024? (Insider Monkey)
Sep-25-24 06:08PM	Why Viking Therapeutics Stock Was So Healthy on Wednesday (Motley Fool)
05:50PM	Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note (Zacks)
Sep-23-24 07:30AM	Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy? (Motley Fool) -7.75%
Sep-21-24 10:39AM	Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers Target? (Insider Monkey)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MACARTNEY LAWSON	Director	Nov 08 '24	Option Exercise	5.80	2,000	11,600	49,965	Nov 08 06:22 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Sale	68.67	2,000	137,333	47,965	Nov 08 06:22 PM
LAWSON MACARTNEY	Director	Nov 08 '24	Proposed Sale	68.67	2,000	137,333		Nov 08 06:13 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '24	Option Exercise	7.49	94,001	704,282	281,053	Oct 28 09:48 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '24	Sale	76.61	131,687	10,089,164	149,366	Oct 28 09:48 PM
GREG ZANTE	Officer	Oct 28 '24	Proposed Sale	78.03	131,687	10,275,537		Oct 28 04:37 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Option Exercise	4.88	11,000	53,680	11,000	Oct 25 07:28 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Sale	80.89	11,000	889,790	0	Oct 25 07:28 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Option Exercise	4.48	16,000	71,680	25,500	Oct 25 07:27 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Sale	79.50	16,000	1,272,000	9,500	Oct 25 07:27 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Proposed Sale	80.86	11,000	889,430		Oct 25 04:10 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Proposed Sale	79.47	16,000	1,271,479		Oct 25 04:01 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Option Exercise	1.19	10,300	12,257	19,800	Sep 20 09:21 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Sale	69.50	10,300	715,850	9,500	Sep 20 09:21 PM
Lian Brian	President & CEO	Sep 20 '24	Option Exercise	7.77	166,130	1,290,830	2,521,057	Sep 20 09:20 PM
Lian Brian	President & CEO	Sep 20 '24	Sale	70.83	216,130	15,308,553	2,304,927	Sep 20 09:20 PM
Lian Brian	Officer	Sep 20 '24	Proposed Sale	18.41	216,130	3,978,372		Sep 20 04:29 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Proposed Sale	69.50	10,300	715,850		Sep 20 04:13 PM
Lian Brian	President & CEO	Aug 21 '24	Option Exercise	7.77	1,000	7,770	2,355,927	Aug 22 07:23 PM
Lian Brian	President & CEO	Aug 21 '24	Sale	69.90	1,000	69,900	2,354,927	Aug 22 07:23 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Option Exercise	1.19	5,700	6,783	15,200	Aug 22 07:23 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Sale	69.72	5,700	397,430	9,500	Aug 22 07:23 PM
Lian Brian	Officer	Aug 21 '24	Proposed Sale	69.90	1,000	69,900		Aug 21 04:30 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Proposed Sale	69.72	5,700	397,404		Aug 21 04:18 PM
Lian Brian	President & CEO	Aug 19 '24	Option Exercise	7.77	112,870	877,000	2,467,797	Aug 19 08:13 PM
Lian Brian	President & CEO	Aug 19 '24	Sale	65.80	112,870	7,426,508	2,354,927	Aug 19 08:13 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Option Exercise	3.33	16,000	53,280	25,500	Aug 19 08:11 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Sale	62.22	16,000	995,453	9,500	Aug 19 08:11 PM
Lian Brian	Officer	Aug 19 '24	Proposed Sale	65.79	112,870	7,425,717		Aug 19 08:00 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Proposed Sale	62.21	16,000	995,360		Aug 19 07:47 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Option Exercise	8.00	20,786	166,288	30,286	Aug 14 08:03 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Sale	57.53	20,786	1,195,736	9,500	Aug 14 08:03 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Proposed Sale	57.53	20,786	1,195,735		Aug 14 04:38 PM
ZANTE GREG	Chief Financial Officer	Jul 30 '24	Sale	57.15	16,136	922,212	187,052	Jul 31 04:05 PM
Lian Brian	President & CEO	Jul 30 '24	Sale	57.58	115,859	6,670,604	2,354,927	Jul 31 04:05 PM
Mancini Marianna	Chief Operating Officer	Jul 30 '24	Sale	57.13	18,026	1,029,912	362,149	Jul 31 04:05 PM
GREG ZANTE	Officer	Jul 30 '24	Proposed Sale	57.15	16,136	922,232		Jul 30 05:58 PM
MARIANNA MANCINI	Officer	Jul 30 '24	Proposed Sale	57.13	18,026	1,029,888		Jul 30 05:56 PM
BRIAN LIAN	Officer	Jul 30 '24	Proposed Sale	57.58	115,859	6,671,057		Jul 30 05:55 PM
ZANTE GREG	Chief Financial Officer	May 03 '24	Option Exercise	4.86	34,249	166,285	241,610	May 03 08:51 PM
ZANTE GREG	Chief Financial Officer	May 03 '24	Sale	74.69	66,756	4,986,008	174,854	May 03 08:51 PM
Mancini Marianna	Chief Operating Officer	May 01 '24	Option Exercise	6.18	281,425	1,740,575	629,933	May 02 09:27 PM
Mancini Marianna	Chief Operating Officer	May 01 '24	Sale	78.66	281,425	22,136,474	348,508	May 02 09:27 PM
Lian Brian	President & CEO	Feb 09 '24	Sale	29.90	45,000	1,345,500	2,139,882	Feb 09 08:59 PM
Lian Brian	President & CEO	Feb 08 '24	Option Exercise	3.76	189,079	711,367	2,404,882	Feb 08 07:40 PM
Lian Brian	President & CEO	Feb 08 '24	Sale	26.87	269,079	7,230,784	2,184,882	Feb 08 07:40 PM
Rouan Sarah Kathryn	Director	Feb 08 '24	Option Exercise	8.32	25,000	208,000	25,000	Feb 08 07:38 PM
Rouan Sarah Kathryn	Director	Feb 08 '24	Sale	28.05	25,000	701,250	0	Feb 08 07:38 PM
Lian Brian	President & CEO	Jan 31 '24	Option Exercise	1.23	85,000	104,550	2,349,882	Jan 31 08:39 PM
Lian Brian	President & CEO	Jan 31 '24	Sale	24.71	85,000	2,100,750	2,264,882	Jan 31 08:39 PM
Lian Brian	President & CEO	Jan 30 '24	Option Exercise	1.23	35,000	43,050	2,299,882	Jan 30 09:05 PM
Lian Brian	President & CEO	Jan 30 '24	Sale	23.95	35,000	838,250	2,264,882	Jan 30 09:05 PM
Rouan Sarah Kathryn	Director	Jan 19 '24	Option Exercise	8.32	30,000	249,600	30,000	Jan 19 08:35 PM
Rouan Sarah Kathryn	Director	Jan 19 '24	Sale	23.05	30,000	691,500	0	Jan 19 08:35 PM
ZANTE GREG	Chief Financial Officer	Jan 04 '24	Sale	17.90	15,000	268,500	180,730	Jan 04 09:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX

Viking Therapeutics Inc

Upgrade your FINVIZ experience